Navigation Links
Oxygen Biotherapeutics, Inc. Seeks Shareholder Approval for Reverse Stock Split
Date:9/9/2009

DURHAM, N.C., Sept. 9 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) announced that the company's proxy, which is being mailed today, asks shareholders to approve a 1-for-15 reverse stock split at the annual meeting on Oct. 19, 2009.

"At last years' general annual meeting we explained the problems of being listed over the counter on the bulletin board and we promised to seek a listing change as soon as we can qualify," said Chris Stern, company chairman and CEO. "We are working toward meeting the listing standards of a major exchange. In that regard we are proposing a reverse split of our outstanding common stock in an effort to meet the minimum stock price qualification requirement of a major stock exchange."

At the meeting, shareholders also will vote on the election of six directors. The current directors have been nominated by the Board for re-election.

The proxy is being mailed today to shareholders of record on Sept. 4, 2009. A copy of the proxy is available on the Investor Relations page of the company website at www.oxybiomed.com.

About Oxygen Biotherapeutics, Inc.

Oxygen Biotherapeutics, Inc. is dedicated to commercializing innovative pharmaceuticals and medical devices in the field of oxygen therapeutics and Defense Medicine(TM). The company has under development a perfluorocarbon (PFC) therapeutic oxygen carrier and liquid ventilation product (Oxycyte(R)) and has out-licensed an implantable glucose sensor. These products are based upon core technologies that include biomedical applications for PFCs as well as medical and industrial applications for biosensors. Each of the product candidates is designed with advantages over currently marketed products in major markets including traumatic brain injury, sickle
'/>"/>

SOURCE Oxygen Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Oxygen Biotherapeutics, Inc. to Present at Investment Conferences in New York and Zurich
2. Oxygen Biotherapeutics, Inc. Files 10-K for Fiscal Year Ended April 30, 2009
3. Oxygen Biotherapeutics, Inc. Announces Closing of Private Placement Financing Agreement
4. Brain Monitor Eliminates Need for Routine Oxygen With Propofol - Friedberg's Triad Unveiled
5. Oxygen Biotherapeutics, Inc. Signs Supply Agreement for Clinical-Grade Oxycyte for Clinical Trials and Future Needs
6. Oxygen Biotherapeutics, Inc. CEO Posts New Blog Entry
7. Webcast Alert: Oxygen Biotherapeutics, Inc. Investor Meeting in Zurich, Switzerland
8. Oxygen Biotherapeutics, Inc. Adds Oxycyte TBI Clinical Trial Sites in Israel
9. Oxygen Biotherapeutics, Inc. Expands Board of Directors
10. Bion Announces Approval of New Australian Patent for Low Oxygen Organic Waste Bioconversion for Livestock Waste Environmental Treatment
11. Sangart, Inc. Completes Enrollment in Second Phase III Study of Hemospan, a Novel Oxygen Transport Agent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... Endologix, Inc. (Nasdaq: ELGX ), developer of ... that Dan Lemaitre, former President and CEO of ... effective December 11, 2009. Endologix now has ... Franklin D. Brown, Chairman of the Board, said, ... the Endologix Board of Directors. He has ...
(Date:12/10/2009)... - YM BioSciences Inc. (NYSE Amex: YMI ... company that identifies and advances a diverse portfolio ... development, today provided an update on the proposed ... Cytopia Ltd. into YM, details of which were ... directors of Cytopia has unanimously recommended that its ...
(Date:12/10/2009)... Pharmaceuticals, Inc.,(OTC Bulletin Board: LTUS) ("Lotus" or ... prescription drugs and licensed national seller of ... ("PRC"), today reported that,effective December 1, 2009, ... Lotus,appointed Mr. Jinzhong HAN to be General ... Division"). , Mr. ...
(Date:12/10/2009)... Antibodies Produces First Candidates Which Selectively Target ... Dec. 10 /PRNewswire-FirstCall/ - YM BioSciences Inc. ... results of a collaborative program between YM ... of Canada,s Biotechnology Research Institute (NRC-BRI). Utilizing ... to generate novel antibodies that target cell ...
Breaking Biology Technology:Endologix Appoints Dan Lemaitre to its Board of Directors 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5
... , , ... , , , ... advances in microfabrication,technology, the development,of a fully automated laboratory on ... handling and,biochemical analysis, "lab-on-a-chip",is revolutionizing life science research. , ...
... , ... , , This Application Note describes ... be used to determine the efficiency,of transfection of mammalian cells using ... with,expression vectors encoding GFP from two different sources, and optimization,of transfection ...
... , , ... , , , ... become an essential tool in any,laboratory working on cell-based studies. ... also the determination of growth factor,and cytokine activity. Even more ...
Other Biology Technology:Agilent 2100 Bioanalyzer,Automated Analysis System 2Agilent 2100 Bioanalyzer,Automated Analysis System 3Agilent 2100 Bioanalyzer,Automated Analysis System 4Agilent 2100 Bioanalyzer,Automated Analysis System 5Agilent 2100 Bioanalyzer,Automated Analysis System 6Monitoring transfection efficiency by,green fluorescent protein (GFP) detection,with the Agilent 2100 bioanalyzer 2Monitoring transfection efficiency by,green fluorescent protein (GFP) detection,with the Agilent 2100 bioanalyzer 3Monitoring transfection efficiency by,green fluorescent protein (GFP) detection,with the Agilent 2100 bioanalyzer 4Monitoring transfection efficiency by,green fluorescent protein (GFP) detection,with the Agilent 2100 bioanalyzer 5Monitoring transfection efficiency by,green fluorescent protein (GFP) detection,with the Agilent 2100 bioanalyzer 6Monitoring transfection efficiency by,green fluorescent protein (GFP) detection,with the Agilent 2100 bioanalyzer 7Cell Proliferation and Viability Measurement 2Cell Proliferation and Viability Measurement 3Cell Proliferation and Viability Measurement 4
(Date:12/14/2009)... The most comprehensive study to date of the proteins ... may provide important clues to how similar regeneration could ... School of Science at Indiana University-Purdue University Indianapolis and ... limbs of axolotls, a type of salamander that has ... level of amputation, with the hope that this knowledge ...
(Date:12/14/2009)... team of researchers from the Astrobiology Centre (INTA-CSIC) has ... essential to the formation of the most basic biological ... In order to carry out this study, published in ... recreated the chemical conditions of the early Earth. , ... in ammoniac solutions it produces hydrogen cyanide, a substance ...
(Date:12/14/2009)... of the United Nations Framework Convention on Climate ... Agency hosted the ,Bend the Trend, event on ... platform and premiere the screening of the new ... of Europe, a joint project of the European ... and ESA, is a series of short films ...
Breaking Biology News(10 mins):IUPUI researchers tackle protein mechanisms behind limb regeneration 2Prussian blue linked to the origin of life 2'Environmental Atlas of Europe' unveiled at COP15 2Microlife WatchBP Series is Proud to Present its Total Concept at the World Hypertension Congress 5866 1Microlife WatchBP Series is Proud to Present its Total Concept at the World Hypertension Congress 5866 2Microlife WatchBP Series is Proud to Present its Total Concept at the World Hypertension Congress 5866 3Siemens Unveils New Hearing Loss Options at SPLASH 3A ADAs 2009 Convention 5863 1Siemens Unveils New Hearing Loss Options at SPLASH 3A ADAs 2009 Convention 5863 2Siemens Unveils New Hearing Loss Options at SPLASH 3A ADAs 2009 Convention 5863 3Siemens Unveils New Hearing Loss Options at SPLASH 3A ADAs 2009 Convention 5863 4Screening for Cardiovascular Diseases Difficult but Necessary 60379 1Screening for Cardiovascular Diseases Difficult but Necessary 60379 2
... Davis, today launched a new "One,Health" program to conserve ... only the gorillas but also the people and,the other ... central,Africa. , With $750,000 in funding from the David ... Gorilla One Health,Program in the School of Veterinary Medicine,s ...
... are astonished at the spectacular recovery of certain coral reefs ... coral bleaching event in 2006. , That year high sea ... Islands, in the southern part of the GBR. The ... seaweed an event that can spell the total loss ...
... A discovery made by researchers at Wake Forest ... explain how some people without a genetic predisposition to ... published this month in the Journal of Neuroscience ... of neurobiology and anatomy, and colleagues, report discovering that ...
Other Biology News:UC Davis launches 'One Health' care for wild mountain gorillas and human neighbors 2UC Davis launches 'One Health' care for wild mountain gorillas and human neighbors 3UC Davis launches 'One Health' care for wild mountain gorillas and human neighbors 4UC Davis launches 'One Health' care for wild mountain gorillas and human neighbors 5Reef boom beats doom 2Researchers discover that gene switches on during development of epilepsy 2Researchers discover that gene switches on during development of epilepsy 3
... This reagent has been developed ... for the reduction of nonspecific background ... Traditional methods describe blocking peroxidase with ... hydrogen peroxide in combination with additional ...
Phospho-Btk (Tyr223) Antibody...
Rad51B...
p27 rabbit polyclonal antibody...
Biology Products: